Proofstock
DashboardScreenerTrack RecordMethodology
DashboardScreenerTrack RecordMethodology
Proofstock
DashboardScreenerTrack RecordMethodology

Proofstock provides quantitative ratings and research based on a transparent six-factor methodology. These ratings are research products, not investment recommendations. We are not a Registered Investment Advisor, and nothing on this site constitutes personalized investment advice. Past performance does not guarantee future results. Consult a licensed financial advisor before making investment decisions.

Proofstock
DashboardScreenerTrack RecordMethodology
As of
July 13, 2026
DashboardScreenerTrack RecordMethodology
← Dashboard

KALV

Strong Bullish

KalVista Pharmaceuticals, Inc.

Healthcare · Biotechnology · $1.42B market cap

Last close
$27.00
0.00% · 1 day
as of Jun 12, 2026
60-day price history
Rating
Strong Bullish99thpercentile
Ranks #5 of 194 in Healthcare

Among the highest-conviction names in the universe on the composite score. Ranks in the 99th percentile overall.

Factor breakdown

Momentum
Quality
Value
Growth
Size
Low Volatility

What this stock is good at

  • Quality

What this stock is not strong at

Nothing notable on this side.

Rating history

Last 27 scored days
Proofstock
DashboardScreenerTrack RecordMethodology

Proofstock provides quantitative ratings and research based on a transparent six-factor methodology. These ratings are research products, not investment recommendations. We are not a Registered Investment Advisor, and nothing on this site constitutes personalized investment advice. Past performance does not guarantee future results. Consult a licensed financial advisor before making investment decisions.

May 17, 2026 · 100thJul 13, 2026 · 99th

Recent factor inputs

The latest raw values feeding the six factors.

P/E
-45.8×
P/B
-375.2×
EV/EBITDA
-331.3×
FCF yield
—
ROE
198.2%
ROIC
-1.7%
Debt / equity
-104.83
Rev growth 3Y
—
EPS growth 3Y
13.9%
12-1 return
99.1%
3M return
59.4%
Realized vol
67.2%